eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

close this panel
←Back

11 – Session in Honor of 70th Birthday of Stephen E. Fienberg and His Nearly 50 Years of Statistical Practice

Construction and Validation of a Parametric Model for Predicting Implant Survivorship Beyond Observed Data in Total Joint Arthroplasty

Sponsor: Biometrics Section
Keywords: Orthopaedic, Total Joint Arthroplasty, Survival, Revision, Exponential Distribution, Prediction

Jennifer Cao

Biomet Orthopedics

Katie Miller

Biomet Orthopedics

Jing Xie

Biomet Orthopedics

In the orthopaedic space, long-term implant survivorship is a critical measure to determine product performance. Construction of a sound statistical model that will predict implant survival beyond the time window of available data is of strong interest and would allow manufacturers to conduct more proactive surveillance on product performance. An accelerated failure time model was fit to short-term survival data from a multi-center clinical trial for a total joint replacement product. The model was used to estimate the survival probability at all time points, including those outside the time window of available data. The model building, model selection, and model diagnostics were demonstrated. Model validation (both internal and external) was performed. An Exponential model (intercept only) was found to be the best-fit model for the data, and satisfied the model assumptions and goodness-of-fit. The internal validation confirmed that the estimates were relatively stable although censoring patterns appear to affect the estimates to some extent. External validation confirmed that this model reliably estimates survivorship within the range of available follow-up time and for approximately 8 years past this interval. Model-predicted survivorship and associated 95% confidence intervals were calculated within the time window of available data and for 8 years outside this interval. This methodology is a viable alternative to the traditional data acquisition methods, and may allow for faster attainment of long-term survivorship information and hence more proactive surveillance on product performance.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2013 CadmiumCD